UK experts say the drug 'Dexamethasone,' which is affordable and highly available worldwide, can reduce the risk of death of patients suffering from Covid-19.
Uk experts have successfully discovered a drug that can reduce the risk of death by a third for those patients suffering from the coronavirus. The drug 'Dexamethasone' is a low-dose steroid treatment that can help the immune system from going into overdrive while fighting off the coronavirus. The best part about this drug is that it is instantly available and affordable worldwide.
The drug Dexamethasone can reduce the risk of death by a third for patients suffering from the deadly coronavirus. It's said that if the experts knew about this drug at the beginning of the pandemic then it could have saved up to 5,000 lives and because of it's cheap price, it could have helped poor countries struggling with patients.
It is believed that this drug helps the body's immune system from going into overdrive as it attempts to fight off Covid-19.
A trial was done by the Oxford University team, in which around 2,000 patients were given the drug and were compared with over 4,000 people who weren't given it.
One of the chief investigators for the trial, Professor Peter Horby, said: "Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result."
"The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients."
Professor Peter Horby, said: "Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide."
Martin Landray, another Chief Investigator, added: "Since the appearance of Covid-19 six months ago, the search has been on for treatments that can improve survival, particularly in the sickest patients."
"These preliminary results from the RECOVERY trial are very clear - dexamethasone reduces the risk of death among patients with severe respiratory complications."
"Covid-19 is a global disease - it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide."